Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Dáil Éireann díospóireacht -
Wednesday, 26 Jan 2000

Vol. 513 No. 1

Written Answers. - Pharmaceutical Products.

Ceist:

461 Dr. Upton asked the Minister for Health and Children the products on the market manufactured by a pharmaceutical firm (details supplied); the concerns, if any, he has regarding the side effects of any of these products; and if he will make a statement on the matter. [1656/00]

The Irish Medicines Board is the competent authority in this country having responsibility for the licensing of medicinal products and for the supervision of their marketing, distribution and supply.

The list of products from the company referred to by the Deputy is available commercially and is included in MIMS – monthly index of medical specialties – and in the recent publication from the Irish Pharmaceutical Healthcare Association, Data Sheet and Summary of Product Characteristics 1999-2000. Each of the products concerned has been evaluated by the IMB and is the subject of product authorisation and accordingly is governed by the general conditions for product authorisation. In addition, the Deputy may be assured therefore, that all authorised medicinal products are subject to ongoing review by the IMB and that a full re-evaluation takes place at the time of renewal, every five years.
Barr
Roinn